SEC Company Response from National Healthcare Properties, Inc. (NHP, HLTC, NHPAP, NHPBP) (CIK 0001561032) (NHP) — Dec 30, 2015
National Healthcare Properties, Inc. (NHP, HLTC, NHPAP, NHPBP) (CIK 0001561032)
Date: Dec. 30, 2015 · CIK: 0001561032 · Accession: 0001144204-15-073257
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-55201
Referenced dates: December 23, 2015
Letter
Via EDGAR Office of Real Estate and Commodities United States Securities and Exchange Commission Division of Corporate Finance File No. 000-55201 Form 10-Q for the quarterly period ended September 30, 2015 Filed November 16, 2015 File No. 000-55201
Dear Mr. Telewicz:
On behalf of Healthcare Trust, Inc., a Maryland corporation (the “Company”), please find transmitted herewith for filing, in connection with the above-captioned Form 10-K (the “Form 10-K”) and Form 10-Q (the “Form 10-Q”) of the Company, the Company’s responses to the comments of the Staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission (the “Commission”) set forth in the Staff’s letter dated December 23, 2015.
The headings and numbered paragraphs below correspond to the headings and numbered paragraphs of the letter. References to page numbers (other than in headings taken from the Staff’s letter) are to pages of the Form 10-K or Form 10-Q.
On behalf of the Company, we respond to the specific comments of the Staff as follows:
Form 10-K for the fiscal year ended December 31, 2014
General
1. On your cover page you disclose the “aggregate market value” of your common stock as of June 30, 2014. In future Exchange Act periodic reports, please revise to reframe this value in a different manner since there is no market for your common stock. To the extent you disclose an aggregate value for the company, please clearly disclose the basis for the per share value used.
The Company undertakes to reframe this value in future Exchange Act periodic reports as requested.
Item 5. Market for Registrant’s Common Equity…
Purchases of Equity Securities by the Issuer and Affiliated Purchasers, page 55
2. We note your disclosure on page 56 regarding the number of repurchase requests and shares repurchased pursuant to your SRP. We understand that the table includes 34 unfulfilled repurchase requests relating to 52,347 shares that were approved for repurchase as of December 31, 2014 and completed in February 2015. It is unclear if the company had any additional unfulfilled repurchase requests. In future Exchange Act reports please clearly disclose the aggregate share amount of redemption requests received, including any unfulfilled requests, during the year or during the period presented in the report.
The Company undertakes to clearly disclose the aggregate share amount of repurchase requests received, including any unfulfilled requests, during the year or during the period presented in future Exchange Act periodic reports as requested.
Form 10-Q for the quarterly period ended September 30, 2015
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Funds from Operations and Modified funds From Operations, page 42
3. In arriving at FFO attributable to common stockholders, you start with net loss. It does not appear you have made an adjustment for non-controlling interest. As a result, it appears FFO is attributable to all equity holders instead of just common stockholders. Please clarify and/or revise title of measure in future periodic filings to adequately reflect what is being presented.
The Company undertakes to clarify the title of the measure in future periodic filings as requested.
The Company acknowledges that:
· the Company is responsible for the adequacy and accuracy of the disclosure in the filing;
· Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing;
· the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Thank you for your consideration of the Company’s response to the Staff’s comments. We appreciate your review and assistance. If you have any questions regarding this response, please do not hesitate to call the undersigned at (312) 962-3567.
Very truly yours,
PROSKAUER ROSE LLP
Show Raw Text
CORRESP
1
filename1.htm
December 30, 2015
Via EDGAR
Robert F. Telewicz, Jr.
Accounting Branch Chief
Office of Real Estate and Commodities
United States Securities and Exchange Commission
Division of Corporate Finance
100 F. Street, N.E.
Washington, D.C. 20549-7010
Re: Healthcare Trust, Inc.
Form
10-K for the fiscal year ended December 31, 2014
Filed
April 15, 2015
File
No. 000-55201
Form
10-Q for the quarterly period ended September 30, 2015
Filed
November 16, 2015
File
No. 000-55201
Dear Mr. Telewicz:
On behalf of Healthcare
Trust, Inc., a Maryland corporation (the “Company”), please find transmitted herewith for filing, in connection
with the above-captioned Form 10-K (the “Form 10-K”) and Form 10-Q (the “Form 10-Q”) of the Company, the
Company’s responses to the comments of the Staff of the Division of Corporation Finance (the “Staff”)
of the Securities and Exchange Commission (the “Commission”) set forth in the Staff’s letter dated December
23, 2015.
The headings and numbered
paragraphs below correspond to the headings and numbered paragraphs of the letter. References to page numbers (other than in headings
taken from the Staff’s letter) are to pages of the Form 10-K or Form 10-Q.
On behalf of the Company,
we respond to the specific comments of the Staff as follows:
Form 10-K for the fiscal year ended
December 31, 2014
General
1. On your cover page you disclose the “aggregate market value” of your common stock
as of June 30, 2014. In future Exchange Act periodic reports, please revise to reframe this value in a different manner since there
is no market for your common stock. To the extent you disclose an aggregate value for the company, please clearly disclose the
basis for the per share value used.
The
Company undertakes to reframe this value in future Exchange Act periodic reports as requested.
Item
5. Market for Registrant’s Common Equity…
Purchases
of Equity Securities by the Issuer and Affiliated Purchasers, page 55
2. We note your disclosure on page 56 regarding the number of repurchase requests and shares repurchased
pursuant to your SRP. We understand that the table includes 34 unfulfilled repurchase requests relating to 52,347 shares that were
approved for repurchase as of December 31, 2014 and completed in February 2015. It is unclear if the company had any additional
unfulfilled repurchase requests. In future Exchange Act reports please clearly disclose the aggregate share amount of redemption
requests received, including any unfulfilled requests, during the year or during the period presented in the report.
The
Company undertakes to clearly disclose the aggregate share amount of repurchase requests received, including any unfulfilled requests,
during the year or during the period presented in future Exchange Act periodic reports as requested.
Form
10-Q for the quarterly period ended September 30, 2015
Item 2. Management’s Discussion
and Analysis of Financial Condition and Results of Operations
Funds from Operations and Modified
funds From Operations, page 42
3. In arriving at FFO attributable to common stockholders, you start with net loss. It does not
appear you have made an adjustment for non-controlling interest. As a result, it appears FFO is attributable to all equity holders
instead of just common stockholders. Please clarify and/or revise title of measure in future periodic filings to adequately reflect
what is being presented.
The
Company undertakes to clarify the title of the measure in future periodic filings as requested.
The Company
acknowledges that:
· the Company is responsible for the adequacy and accuracy of the disclosure in the filing;
· Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission
from taking any action with respect to the filing;
· the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission
or any person under the federal securities laws of the United States.
Thank you for your
consideration of the Company’s response to the Staff’s comments. We appreciate your review and assistance. If you have
any questions regarding this response, please do not hesitate to call the undersigned at (312) 962-3567.
Very truly yours,
PROSKAUER ROSE LLP
By:
/s/ Michael J. Choate
Michael J. Choate
cc: Katie P. Kurtz
James
A. Tanaka, Esq.
Peter
M. Fass, Esq.